Cost-effectiveness of interferon-α for chronic myeloid leukemia

被引：1
|
作者：
Goldman, JM [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London, England
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷 / 04期
关键词：
D O I：
10.1023/A:1008201711045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：351 / 352
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of alpha-interferon (IFN) treatment in chronic myeloid leukemia (CML)
    Liberato, NL
    Quaglini, S
    Barosi, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 272 - 272
  • [2] Cost-effectiveness of interferon alfa in chronic myelogenous leukemia
    Liberato, NL
    Quaglini, S
    Barosi, G
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2673 - 2682
  • [3] Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy
    Lucioni, Carlo
    Iannazzo, Sergio
    Mazzi, Silvio
    Saporiti, Giorgia
    Chiroli, Silvia
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (01) : 1 - 16
  • [4] alpha-interferon versus hydroxyurea in chronic myeloid leukemia: A cost-effectiveness analysis.
    Liberato, NL
    Quaglini, S
    Bellazzi, R
    Guarnone, R
    Barosi, G
    BLOOD, 1995, 86 (10) : 3175 - 3175
  • [5] Cost-effectiveness of imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia
    Reed, SD
    Anstrom, KJ
    Ludmer, JA
    Glendenning, GA
    Schulman, KA
    CANCER, 2004, 101 (11) : 2574 - 2583
  • [6] A MARKOV MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF OMACETAXINE IN CHRONIC MYELOID LEUKEMIA
    Brereton, N. J.
    Batty, A. J.
    Foy, C. F.
    McCormick, A. L.
    VALUE IN HEALTH, 2010, 13 (07) : A269 - A269
  • [7] Cost-effectiveness of imatinib versus interferon-α in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.
    Mataveli, Fabio
    Calabro, Alessandra
    Mendes, Wellington
    Vianna, Denizar
    Dorlhiac-Llacer, Pedro
    Bigni, Ricardo
    Hungria, Vania
    BLOOD, 2006, 108 (11) : 946A - 946A
  • [8] Cost-effectiveness analysis of interferon-α therapy in the treatment of chronic hepatitis B in Taiwan
    Pwu, RF
    Chan, KA
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (09) : 632 - 641
  • [9] Cost-effectiveness of interferon therapy in chronic myeloid leukemia [Kosteneffektivitat der interferontherapie bei chronisch myeloischer leukamie]
    Liberato N.L.
    Barosi G.
    Der Onkologe, 1999, 5 (7): : 586 - 589
  • [10] Cost-effectiveness of interferon in chronic myeloid leukaemia: Analysis of four clinical studies
    Messori, A
    ANNALS OF ONCOLOGY, 1998, 9 (04) : 389 - 396
12345